Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia

ABSTRACTChronic lymphocytic leukemia (CLL) is the most common adult leukemia in the western world. It is characterized by a high dependency on interactions with the surrounding immune landscape, highlighting its suitability for immune-mediated therapeutic interventions. We recently revealed that the...

Full description

Bibliographic Details
Main Authors: Iria Fernandez Botana, Giulia Pagano, Etienne Moussay, Jerome Paggetti
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:OncoImmunology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/2162402X.2023.2276490
_version_ 1797367122288967680
author Iria Fernandez Botana
Giulia Pagano
Etienne Moussay
Jerome Paggetti
author_facet Iria Fernandez Botana
Giulia Pagano
Etienne Moussay
Jerome Paggetti
author_sort Iria Fernandez Botana
collection DOAJ
description ABSTRACTChronic lymphocytic leukemia (CLL) is the most common adult leukemia in the western world. It is characterized by a high dependency on interactions with the surrounding immune landscape, highlighting its suitability for immune-mediated therapeutic interventions. We recently revealed that the cytokine IL-27 exerts a strong anti-tumor role in CLL through a T-cell-mediated mechanism.
first_indexed 2024-03-08T17:12:50Z
format Article
id doaj.art-6ccff743e491466b95b6ae76421016ba
institution Directory Open Access Journal
issn 2162-402X
language English
last_indexed 2024-03-08T17:12:50Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series OncoImmunology
spelling doaj.art-6ccff743e491466b95b6ae76421016ba2024-01-03T19:25:36ZengTaylor & Francis GroupOncoImmunology2162-402X2023-12-0112110.1080/2162402X.2023.2276490Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemiaIria Fernandez Botana0Giulia Pagano1Etienne Moussay2Jerome Paggetti3Tumor Stroma Interactions, Department of Cancer Research, Luxembourg Institute of Health, LuxembourgTumor Stroma Interactions, Department of Cancer Research, Luxembourg Institute of Health, LuxembourgTumor Stroma Interactions, Department of Cancer Research, Luxembourg Institute of Health, LuxembourgTumor Stroma Interactions, Department of Cancer Research, Luxembourg Institute of Health, LuxembourgABSTRACTChronic lymphocytic leukemia (CLL) is the most common adult leukemia in the western world. It is characterized by a high dependency on interactions with the surrounding immune landscape, highlighting its suitability for immune-mediated therapeutic interventions. We recently revealed that the cytokine IL-27 exerts a strong anti-tumor role in CLL through a T-cell-mediated mechanism.https://www.tandfonline.com/doi/10.1080/2162402X.2023.2276490CytokineIL-27CD8+ T cellsimmunotherapyleukemia
spellingShingle Iria Fernandez Botana
Giulia Pagano
Etienne Moussay
Jerome Paggetti
Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia
OncoImmunology
Cytokine
IL-27
CD8+ T cells
immunotherapy
leukemia
title Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia
title_full Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia
title_fullStr Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia
title_full_unstemmed Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia
title_short Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia
title_sort interleukin 27 tackles immunosuppression in chronic lymphocytic leukemia
topic Cytokine
IL-27
CD8+ T cells
immunotherapy
leukemia
url https://www.tandfonline.com/doi/10.1080/2162402X.2023.2276490
work_keys_str_mv AT iriafernandezbotana interleukin27tacklesimmunosuppressioninchroniclymphocyticleukemia
AT giuliapagano interleukin27tacklesimmunosuppressioninchroniclymphocyticleukemia
AT etiennemoussay interleukin27tacklesimmunosuppressioninchroniclymphocyticleukemia
AT jeromepaggetti interleukin27tacklesimmunosuppressioninchroniclymphocyticleukemia